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ABSTRACT 
 
Coral reef is a productive ecosystem with high biodiversity in the sea and being targeted to find a useful 
bioactive compound. However, the serious problem in development of bioactive compounds from marine 
invertebrate is the supply problem, because to get a small amounts of active compounds a massive numbers 
of sea organisms are needed. Tunicate is an animal in coral reef ecosystem that produces many bioactive 
compounds with pharmacological activities, such as, antibacterial, antitumor, and anticancer compounds. It 
has been reported that bacterial symbionts of coral reef invertebrates may synthesize the same compounds as 
the host. The purposes of this research are to isolate and to identify microbes which have antibacterial 
activity against MDR bacteria based PCR 16S rRNA and to detect the existence of  PKS and NRPS 
biosynthetic gene fragments from tunicate bacteria of Didemnum molle. Out of 15 bacterial isolates, one 
isolate showed antibacterial potential against Escherichia coli and Staphylococcus sp. Molecular 
identification result showed that TS2A5 bacterium has a homology of 99 % with Virgibacillus sp. strain 
GSP17 16S ribosomal RNA gene. This isolate was also capable of amplifying  NRPS gene fragment. 
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INTRODUCTION 
 
Antimicrobial resistance has become a major 
health problem worldwide, both in hospitals 
and the community. The emergence of 
antimicrobial resistance is correlated with 
selective pressure from the use, often 
inappropriate, of antimicrobial agents and 
results in increased mortality, morbidity, and 
health care costs (Cohen, 1994; Lestari et al., 
2007). 
Utilization of antibiotics is directly or 
indirectly will increase the prevalence of 
resistance of bacterial pathogens or normal flora 
that will develop into a multi-drug resistant 
strains (MDR). The alternative for antibiotic 
compounds that have been resistant bacteria has 
become a very urgent need (Hunt and Vincent, 
2006). 
The ocean is a major source of organisms 
that produce bioactive compounds (Bernan et 
al., 1997; Proksch et al., 2002). Prospectors of 
bioactive compounds look for them in slow 
moving or sessile marine invertebrates that have 
no protective structures such as spines or shells 
(Flam, 1994). However, in most instances the 
amounts of the compounds produced by these 
organisms are relatively small and thus not 
likely to satisfy any industrial demands 
(Proksch et al., 2002).  
The oceans are the source of a large 
group of structurally unique natural products 
that are mainly accumulated in invertebrates 
such as sponges, tunicates, bryozoans, and 
molluscs. Several of these compounds such as 
the tunicate metabolite ET-743, a potent anti-
cancer agent, is obtained from Ecteinescidia 
turbinata, a tunicate from the Caribbean sea 
(Rinehart et al., 1990) show pronounced 
pharmacological activities and are interesting 
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candidates for new drugs primarily in the area 
of cancer treatment (Proksch et al., 2002). 
Recent evidence shows that at least some 
of the bioactive compounds isolated from 
invertebrates are of microbial origin (Davidson 
et al., 2001; Lim and Haygood, 2004; Schmidt 
et al., 2005). Since bacteria are known to 
produce metabolites similar to ET-743, 
isolation and identification of the putative 
metabolite-producing bacteria associated with 
E. turbinata may reveal a new approach for the 
production of this compound (Proksch et al., 
2002). 
In this work, we report the potential of 
marine bacterium associated with tunicate 
Didemnum molle for the production of 
secondary metabolites against pathogenic 
Staphylococcus sp. and E. coli coupled with 
PCR based-screening for the presence of          
non-ribosomal polypeptide synthetases.  
 
MATERIALS AND METHODS 
 
Collection of samples and bacterial isolation 
 
Colonies of tunicate Didemnum molle were 
collected from Sambangan waters, 
Karimunjawa islands, North Java Sea, 
Indonesia by scuba diving from a depth of 
approximately 2 meter. Upon collection 
colonies were put into sterile plastic bags 
(Whirl-Pak, Nasco, USA) and put into cool-
box. The tissues were then rinsed with sterile 
seawater and cut with a sterile knife. The 
resultant tissues were serially diluted, spread on 
½ strength ZoBell 2216E marine agar medium 
and incubated at room temperature for 2x24 
hours. On the basis of morphological features, 
colonies were randomly picked and purified by 
making streak plates (Madigan et al., 2000). 
 
Inhibitory interaction test 
 
Inhibitory interaction test of bacterial isolates 
against pathogenic Staphylococcus sp. and E. 
coli, was performed by using the agar disk 
diffusion method. One hundreed microliter 
culture of target microorganism in the 
logaritmic phase (ca.10
9
 cells mL
-1
) was spread 
on to agar medium. (Paper disks 8 mm; 
Advantec, Toyo Roshi, Ltd, Japan) containing 
25 µl of the tunicate bacterial strain were placed 
on the respective agar surface. The plates were 
then incubated at room temperature for 48 h. 
Antibacterial activity was defined according to 
Radjasa et al., (2007a) by the formation of 
inhibition zones greater than 9 mm around the 
paper disk. 
The following MDR strain bacteria 
Staphylococcus sp. and E. coli, obtained from 
Dr. Kariadi Hospital in Semarang, Central Java, 
Indonesia as described  Lestari et al., (2007) 
were used as a tested strains. 
 
Polymerase Chain Reaction 16S rRNA 
 
Genomic DNA of strains for PCR analysis were 
obtained from cell materials taken from an agar 
plate, suspended in sterile  water (Sigma, 
Germany) and subjected to five cycles of freeze 
(-80
o
C) and thaw (95
o
C). PCR amplification or 
partial 16S rRNA gene of tunicate associated 
bacteria and subsequent sequencing analysis 
were performed according to method of Radjasa 
et al., (2007b). The determined DNA sequences 
of strains were then compared for homology to 
the BLAST database. 
 
PCR based screening of NRPS producing 
bacterial strains 
 
Non-ribosomal peptide synthetases (NRPS) 
primers were prepared and amplification of  
peptide synthetase gene fragments was carried 
out with the NRPS degenerated primers as 
described  (Radjasa et al., 2007a). PCR 
amplification of partial 16S rRNA gene of 
marine bacterium TS2A5, purification of PCR 
products and subsequent sequencing analysis 
were performed according to the methods of 
Thiel and Imhoff (2003), respectively. The 
determined DNA sequences of strains were then 
compared for homology to the BLAST 
database.  
 
RESULTS AND DISCUSSION 
 
Screening among 15 marine bacteria associated 
with tunicate Didemnum molle by using test 
organism revealed that only one isolate, TS2A5 
capable of inhibiting the growth of 
Staphylococcus sp. and E. coli, while the rest of 
isolates showed no activity. The measurement 
of inhibition zone as indicator of the 
antibacterial potential of isolate TS2A5 against 
pathogenic bacterium is presented in Table 1. 
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As shown in the Fig. 1, the isolate was also 
capable of amplifying the gene fragments of 
Non-ribosomal peptide synthetases (NRPS) 
indicated by the presence of single band having 
similar height to the positive control of 
Pseudomonas fluorescens DSM 50117.  
 
Table 1. Antibacterial activity of isolate TS2A5 against pathogenic Staphylococcus sp. and 
Escherichia coli 
Isolate Tested pathogen Inhibition Zone 
(cm) 
Tested pathogen Inhibition Zone 
(cm) 
TS2A5 Escherichia coli 1.05 ± 0.87 Staphylococcus sp. 1.79 ± 0.534 
 
 
                                               M                   TS2A5              + 
 
Fig.1. PCR amplification of NRPS gene fragments;   +   control Pseudomonas fluorescens  DSM No. 50117; 
M is DNA markers 
 
Molecular identification of actives isolates of 
marine bacteria associated with tunicate based 
on 16S rRNA, revealed that active strain 
TS2A5 was closely related to Virgibacillus sp. 
(Table 2). Phylogenetic tree shown in Fig.2. 
shows the phylogenetic affiliation of bacterial 
isolate with other microorganisms. 
 
Fig 2. Neighbor joining tree showing phylogenetic topology of strain TS2A5 with other species and related 
taxa based on 16S rRNA gene sequence. Bootsrap values from 1000 resamplings are indicated. 
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    Table 2. Molecular identification of active isolate obtained from marine tunicate. 
No Isolate Length Closest Relative Similarity (%) Accession 
1 TS2A5 1333 bp Virgibacillus sp. 99 % EU868858.1 
 
An attempt was carried out to estimate 
the potential of marine bacteria associated with 
tunicate Didemnum molle from Sambangan 
island as the source of antibacterial compounds     
in particular against the pathogenic 
Staphylococcus sp. and E. coli. 
Tunicates have been known to produce 
secondary metabolites such as ET-743 a potent 
anti-cancer agent, obtained from Ecteinescidia 
turbinata, a tunicate from the Caribbean sea. 
Since ET-743 has been found from tunicate E. 
turbinate samples both in the Caribbean and in 
the Mediterranean and the compound is likely 
to be bacterial in origin. Thus, it is possible that 
the bacteria responsible for its production are 
associated with the tunicate from both regions 
(Rinehart et al., 1990 ; Mendola 2000).  
A number of compounds with biomedical 
potential have been isolated from marine 
invertebrates, especially sponges and tunicates. 
There is now evidence that some of these 
compounds are synthesized by bacteria 
associated with the invertebrates (Schmidt et 
al., 2000). For other biologically active 
compounds there is only circumstantial 
evidence that they could come from bacteria 
associated with the invertebrate (Koenig et al., 
2005). 
It is interesting to note that tunicate 
bacterium Virgibacillus sp. TS2A5 showed 
strong growth inhibition against Staphylococcus 
sp. and E. coli. This raises the possibility the 
use of tunicate bacteria as the source of 
antibacterial compounds for controlling the 
pathogenic bacteria Staphylococcus sp. and E. 
coli. 
Our results highlight tunicate-associated 
bacterium (TS2A5) carrying the NRPS gene. 
Growth inhibition of pathogenic bacterium by 
NRPS strain TS2A5 demonstrates the 
uncharacterized secondary metabolites 
produced by strain TS2A5 lead to antagonistic 
activity.   
TS2A5 is characterized by Gram-positive 
and motile by means of peritrichous flagella. 
Terminal or subterminal spore position. 
Colonies are irregular to regular, flat and 
translucent, and milky white in colour. Optimal 
growth occurs at 35-40 
o
C. 
The genus Virgibacillus was first 
proposed by Heyndrickx et al., (1998). 
Recently, the 12 members of genus 
Virgibacillus sp. have been validly described: V. 
pantothenticus, V. proomii, V. carmonensis, V. 
necropolis, V. picturae, V. marismortui, V. 
salexigens, V. halodenitrificans, V. dokdonensis 
(Yoon et al., 2005), V. koreensis (Lee et al., 
2006), V. olivae and V. halophilus (An et al., 
2007). 
This genus is characterized by A gram-
positive, motile, endospore-forming, halophilic 
bacterial strain, DNA G+C content (mol%) 36.7 
(V. dokdonensis)- 42.8 (V. marismortui) (Wang 
et al., 2008).  
The genus Virgibacillus has been 
implicated in the production of a number of 
biotechnologically relevant biomolecules. A 
typical example of enzymes would include 
proteases. The enzyme proteases are found to 
be produced or secreted most by the genus 
Virgibacillus and are of particular interest due 
to their wide applications in, protein recovery or 
solubilization, organic synthesis, meat 
tenderization, detergents, food industry, and 
pharmaceuticals (Gupta et al., 2008).  
Other studies have reported amylases 
bioflocculant compound, and antifungal 
compound production by some Virgibacillus 
species (Essghaier et al., 2009). Although as 
mentioned a number of bioactive compounds 
have been documented to be produced by 
Virgibaccillus species (Cosa et al., 2011).  
 
CONCLUSION 
 
In conclusion, the present study highlighted the 
potential use of tunicate associated bacteria in 
inhibiting the growth of pathogenic bacteria 
Staphylococcus sp and E. coli. This finding can 
be developed further in order to obtain 
sustainable source of marine marine 
antimicrobial compounds. 
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